Reuse Data From OEMs Could Jumpstart FDA Policy-making Effort
This article was originally published in The Gray Sheet
Executive Summary
Approximately 80% of commercially reprocessed biopsy forceps are not completely sterilized prior to reuse, according to data submitted to FDA by the Association of Disposable Device Manufacturers.